to Content
Header Image

Epidemics – Pandemics

-
Erwin-Schrödinger-Saal
Plenary / Panel
German and English language
Vice President Research and Development, Baxter Vaccine AG, Orth an der Donau
Executive Vice President of Research & Development, Gilead Sciences, Inc., Foster City
Director, Max Planck Institute for Dynamics and Self-Organization, Göttingen; Professor of Theoretical Physics, University of Göttingen
Professor and Chair, Department of Microbiology, Mount Sinai School of Medicine, New York
Special Advisor on Influenza Pandemic Vaccine Development, WHO, Initiative for Vaccine Research, Department for Immunization, Vaccines and Biologicals, Geneva
Geschäftsführer, Ze.Wa. medicalsystems GmbH, Wien

Dr. Noel BARRETT

Vice President Research and Development, Baxter Vaccine AG, Orth an der Donau

 Dr. Noel Barrett is Vice-President, Vaccines Research in the Bioscience Division of Baxter Healthcare. He received his B. Sc. in Microbiology at University College Cork, Ireland (1976) and his Ph. D. in Virology at Trinity College, Dublin (1979). He subsequently held a post-doctoral fellowship at the Dept. of Virology and Immunology, University of Würzburg, Germany for a period of four years. In 1983, he joined the Austrian company Immuno AG, which was subsequently acquired by Baxter Healthcare in 1997.
 Dr. Barrett has been responsible for a variety of functions in the Vaccine business unit including discovery research, clinical development, regulatory affairs and project management, in addition to being responsible for the pathogen safety program of the plasma division for a period of over ten years. He is currently a member of the Baxter AG, Austria board of directors, the Baxter International Senior Management Team and is site manager of the Biomedical Research Centre in Orth. Dr. Barrett has had over twenty years experience in the vaccine industry with management responsibilities covering the complete development process required to bring vaccine products to the market.

PhD Norbert W. BISCHOFBERGER

Executive Vice President of Research & Development, Gilead Sciences, Inc., Foster City

Postdoctoral Fellow, Syntex Inc., Palo alto, CA Postdoctoral Fellow, Harvard University, Cambridge, MA Scientist, Genentech Inc. Vice President of Research, Gilead Vice President of Research & Development, Gilead
1983-1984
1984-1986
1986-1990
1990-1997
1997-2000

Dr. Theo GEISEL

Director, Max Planck Institute for Dynamics and Self-Organization, Göttingen; Professor of Theoretical Physics, University of Göttingen

Dr. rer. Nat. Theoretical Physics, University of Regensburg Habilitation Theoretical Physics, University of Regensburg Professor of Theoretical Physics, University of Würzburg Professor of Theoretical Physics, University of Frankfurt Professor of Theoretical Physics, University of Göttingen
 Studies of Physics and Mathematics at the Universities of Frankfurt and Regensburg
1975
1982
1988-1989
1989-1996
since 1996
 Director, Institute for Nonlinear Dynamics, University of Göttingen
 Head, Bernstein Center für Computational Neuroscience, Göttingen

Ph.D. Peter PALESE

Professor and Chair, Department of Microbiology, Mount Sinai School of Medicine, New York

 Ph.D Chemistry, University of Vienna
 Mag. pharm., University of Vienna
 Postdoctoral Fellow, Roche Institute of Molecular Biology, Nutley, New Jersey
 Professor and Chair, Department of Microbiology, Mount Sinai School of Medicine

Dr. Klaus STÖHR

Special Advisor on Influenza Pandemic Vaccine Development, WHO, Initiative for Vaccine Research, Department for Immunization, Vaccines and Biologicals, Geneva

Research Fellow, Department of Public Veterinary Medicine, Faculty of Veterinary Medicine, University of Leipzig Scientist, Institute for Epidemiology and Communicable Disease Control, Federal Research Institute Wusterhausen/Tübingen Head, Division of Infectious Diseases, Institute for Epidemiology and Communicable Disease Control, Federal Research Institute Wusterhausen/Tübingen Associated Professional Officer (P2); WHO Division of Communicable Diseases, Veterinary Public Health Unit, Geneva Scientist (P5); WHO Division of Communicable Diseases, Veterinary Public Health Unit Scientist (P5); WHO Division for Emerging and other Communicable Diseases Surveillance and Control Senior Scientist (P5); WHO Department of Communicable Diseases Surveillance and Response Project Leader (P5); WHO Global Influenza Programme; WHO Department of Communicable Diseases Surveillance and Response Coordinator (P5); SARS Aetiology, Diagnosis and Treatment, WHO Department of Communicable Diseases Surveillance and Response Coordinator (P5); WHO Global Influenza Programme WHO Department of Communicable Diseases Surveillance and Response
1984-1987
1987-1989
1989-1991
1992-1993
1994-1995
1995-1998
1998-2001
2001-2004
2003
2004-2006

Dr. Hubert DRESSLER

Geschäftsführer, Ze.Wa. medicalsystems GmbH, Wien

Medizinstudium, Universität Wien, Abschluss mit Doktorat; außerdem Studien in Geschichte und Ethnologie Postgraduate Economics, European Business School, Eltville, Deutschland Internship, Medical University of Otago, Dunedin, New Zealand Internship, Children's Hospital Oakland, California, USA Pharma-Produktmanager, Hoechst Austria AG Produktmanager Herz-Kreislauf, Pharma Sales International, Hoechst AG, Frankfurt Leiter Pharma, Nigerian Hoechst PLC Stv. Geschäftsführer, Leiter Pharma, verantwortlich für Pharma-, Landwirtschafts- und Veterinärprodukte, Corporate Center, Projektarbeit Afrika, Hoechst AG, Frankfurt Assistent von Dr. Seifert, Vorstandsmitglied der Hoechst AG, Frankfurt Managing Director, verantwortlich für Pharma-, Diagnostika- und Veterinärprodukte in der Volksrepublik China, Geschäftsführer, Österreich/Central Europe, Hoechst Marion Roussel Geschäftsführer, Aventis Pharma GmbH Head of Area, Austria & Switzerland, Aventis Pharma GmbH General Manager, sanofi-aventis Österreich, Wien Präsident, Verband der pharmazeutischen Industrie Österreichs, Wien
1976-1985
1990-1991
1985-1986
1986-1987
1987-1990
1990-1991
1991-1992
  Nigerian Hoechst PLC
1992-1993
1993-1994
1994-1995
  Hongkong und Taiwan, Hoechst Marion Roussel
1995-1998
1998-2000
2000-2001
2001-2004
2004-2008
2004-2010

Health Symposium

show timetable